Literature DB >> 25980998

Practical application of new technologies for melanoma diagnosis: Part I. Noninvasive approaches.

Jordon March1, Matthew Hand2, Douglas Grossman3.   

Abstract

Confirming a diagnosis of cutaneous melanoma requires obtaining a skin biopsy specimen. However, obtaining numerous biopsy specimens-which often happens in patients with increased melanoma risk-is associated with significant cost and morbidity. While some melanomas are easily recognized by the naked eye, many can be difficult to distinguish from nevi, and therefore there is a need and opportunity to develop new technologies that can facilitate clinical examination and melanoma diagnosis. In part I of this 2-part continuing medical education article, we will review the practical applications of emerging technologies for noninvasive melanoma diagnosis, including mobile (smartphone) applications, multispectral imaging (ie, MoleMate and MelaFind), and electrical impedance spectroscopy (Nevisense).
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MelaFind; MoleMate; Nevisense; melanoma; mobile app; spectroscopy; teledermatology

Mesh:

Year:  2015        PMID: 25980998     DOI: 10.1016/j.jaad.2015.02.1138

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Identification of melanoma cells: a method based in mean variance of signatures via spectral densities.

Authors:  Esperanza Guerra-Rosas; Josué Álvarez-Borrego; Aracely Angulo-Molina
Journal:  Biomed Opt Express       Date:  2017-03-15       Impact factor: 3.732

2.  Skin Cancer: Have melanoma and skin cancer finally met their match?

Authors:  Jeffrey E Gershenwald; Kelly C Nelson
Journal:  Nat Rev Clin Oncol       Date:  2017-04-19       Impact factor: 66.675

3.  Differentiation of seborrheic keratosis from basal cell carcinoma, nevi and melanoma by RGB autofluorescence imaging.

Authors:  Alexey Lihachev; Ilze Lihacova; Emilija V Plorina; Marta Lange; Alexander Derjabo; Janis Spigulis
Journal:  Biomed Opt Express       Date:  2018-03-23       Impact factor: 3.732

Review 4.  Emerging imaging technologies in dermatology: Part II: Applications and limitations.

Authors:  Samantha L Schneider; Indermeet Kohli; Iltefat H Hamzavi; M Laurin Council; Anthony M Rossi; David M Ozog
Journal:  J Am Acad Dermatol       Date:  2018-12-04       Impact factor: 11.527

Review 5.  Reflectance confocal microscopy of skin in vivo: From bench to bedside.

Authors:  Milind Rajadhyaksha; Ashfaq Marghoob; Anthony Rossi; Allan C Halpern; Kishwer S Nehal
Journal:  Lasers Surg Med       Date:  2016-10-27       Impact factor: 4.025

Review 6.  Teledermatology Addressing Disparities in Health Care Access: a Review.

Authors:  Spandana Maddukuri; Jay Patel; Jules B Lipoff
Journal:  Curr Dermatol Rep       Date:  2021-03-12

7.  Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study.

Authors:  Janne Räsänen; Mari Salmivuori; Ilkka Pölönen; Mari Grönroos; Noora Neittaanmäki
Journal:  Acta Derm Venereol       Date:  2021-02-19       Impact factor: 3.875

8.  Cervical cancer screening in low-resource settings: a smartphone image application as an alternative to colposcopy.

Authors:  Caroline Gallay; Anne Girardet; Manuela Viviano; Rosa Catarino; Anne-Caroline Benski; Phuong Lien Tran; Christophe Ecabert; Jean-Philippe Thiran; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Womens Health       Date:  2017-06-22

Review 9.  Ultrasound and Infrared-Based Imaging Modalities for Diagnosis and Management of Cutaneous Diseases.

Authors:  Sheliza Halani; F Stuart Foster; Maksym Breslavets; Neil H Shear
Journal:  Front Med (Lausanne)       Date:  2018-04-25

10.  Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer.

Authors:  Esra Sarac; Andreas Meiwes; Thomas Eigentler; Stephan Forchhammer; Lukas Kofler; Hans-Martin Häfner; Claus Garbe
Journal:  Acta Derm Venereol       Date:  2020-11-23       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.